1. Home
  2. AVNW vs SLN Comparison

AVNW vs SLN Comparison

Compare AVNW & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$21.34

Market Cap

275.0M

Sector

Technology

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$6.21

Market Cap

318.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNW
SLN
Founded
2006
1994
Country
United States
United Kingdom
Employees
923
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.0M
318.4M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
AVNW
SLN
Price
$21.34
$6.21
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$32.50
$39.67
AVG Volume (30 Days)
97.4K
305.7K
Earning Date
02-03-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$453,497,000.00
$25,830,000.00
Revenue This Year
$5.73
N/A
Revenue Next Year
$6.79
N/A
P/E Ratio
$20.79
N/A
Revenue Growth
10.72
40.39
52 Week Low
$15.80
$1.97
52 Week High
$26.83
$8.08

Technical Indicators

Market Signals
Indicator
AVNW
SLN
Relative Strength Index (RSI) 48.17 46.42
Support Level $20.77 $5.99
Resistance Level $21.83 $6.59
Average True Range (ATR) 0.72 0.43
MACD 0.10 -0.03
Stochastic Oscillator 54.39 25.22

Price Performance

Historical Comparison
AVNW
SLN

About AVNW Aviat Networks Inc.

Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: